NC | SCD | MCI | Dementia | |
---|---|---|---|---|
No., % | 119, 25.3% | 207, 44.0% | 87, 18.5% | 57, 12.1% |
Age, years | 66(9.2,55–89) | 66(7.9,55–86) | a, b69(10,58–89) | a, b73(12.6,57–86) |
APOE-ε4 (No., %) | 24, 20.2% | 36, 17.4% | a, b35, 40.2% | a, b27, 47.4% |
Female (No., %) | 72, 60.5% | a, c, d154, 74.4% | 48, 55.2% | 31, 54.4% |
Education, years | 13(4.0,5–20) | 14(4.3,2–24) | a, b12(6.0,2–18) | a, b11(4.0,0–18) |
MoCA | 27 (3) | 26 (4) | a, b22 (5) | a, b, c12 (7) |
MMSE | 29 (3) | 29 (3) | a, b26 (4) | a, b, c18 (8) |
Participants with risk factors (n = 443) | ||||
No., % | 115, 26.0% | 197, 44.5% | 79, 17.8% | 52, 11.7% |
Hypertension (No., %) | 24, 20.2% | 41, 19.8% | 18, 20.7% | 8, 14.0% |
Diabetes (No., %) | 10, 8.4% | 18, 8.7% | 7, 8.0% | 7, 12.3% |
Hyperlipidemia (No., %) | 21, 17.6% | a65, 31.4% | b10, 11.5% | 7, 12.3% |
PSQI | 5.5 (4) | a, d7.0 (5) | a, d6.0 (6) | a, b, c4.0 (4.3) |
GDS | 2 (2) | a, c, d2 (3) | a, b3 (4) | a, b3 (4) |
Participants with MRI image data (n = 301) | ||||
No., % | 73, 24.3% | 132, 43.9% | 57, 18.9% | 39, 13.0% |
Age, years | 66(8.9,55–89) | 67(8.0,55–86) | a69(9.0,58–89) | a, b73(13.3,57–85) |
APOE-ε4 (No., %) | 19, 26.0% | 24, 18.2% | b22, 38.6% | a, b20, 51.3% |
Female (No., %) | 43, 58.9% | 94, 71.2% | 33, 57.9% | 23, 59.0% |
MoCA | 26 (3) | 26 (3) | a, b22 (5) | a, b, f12 (7.5) |
MMSE | 29 (2) | 29 (3) | a, b26 (3) | a, b, f18 (9) |
Participants with Aβ PET image data (n = 195) | ||||
No., % | 43, 22.0% | 80, 41.0% | 44, 22.6% | 28, 14.4% |
Age, years | 66(8.6,55–89) | 67(7.4,55–81) | a, b69(9.1,58–89) | a, b73(12.7,58–85) |
APOE-ε4 (No., %) | 13, 30.2% | 12, 15.0% | b18, 40.9% | b15, 53.6% |
Female (No., %) | 24, 55.8% | 52, 65.0% | 24, 54.5% | 17, 60.7% |
MoCA | 26 (4) | 26 (3) | a, b23 (5) | a, b, e13.5 (10.5) |
MMSE | 28 (2) | 29 (3) | a, b27 (3) | a, b, e18 (8.25) |
Participants with tau PET image data (n = 70) | ||||
No., % | 18, 25.7% | 23, 32.9% | 18, 25.7% | 11, 15.7% |
Age, years | 65(12.7,55–89) | 65(6.0,57–80) | 70(8.5,58–78) | 62(10.4,58–80) |
APOE-ε4 (No., %) | 7, 38.9% | 11, 47.8% | 11, 61.1% | 7, 63.6% |
Female (No., %) | 8, 44.4% | 17, 73.9% | 9, 50.0% | 6, 54.5% |
MoCA | 26.5 (4) | 26 (5.5) | a, b22 (5.75) | a, b, f12 (8.5) |
MMSE | 28.5 (3) | 28 (3) | b26 (3.75) | a, b, f13 (9) |